Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting

White Paper

ROXADUSTAT - a multipronged development strategy

In this whitepaper, we outline how various strategies for the development of Roxadustat resulted in a successful filling of the USDMF in March 2020 to help our partners across geographies provide patients early treatment access.

Roxadustat is a first-in-class small molecule oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) and increases the endogenous production of erythropoietin, which stimulates the production of haemoglobin and red blood cells. This innovative approach has ordered a breakthrough in treating patients with anaemia in chronic kidney disease (CKD).

We can address customized particle size distribution requirements through size reduction and crystallization techniques to meet the most desired particle size distributions consistently at a commercial scale.

To know more about our offerings , please read the technical sheet on Roxadustat by filling the contact from below.
 

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Company

Contact Us

Follow Us on

  • Twitter

Dr. Reddy’s Laboratories, 8-2-337,
Banjara Hills Rd Number 3,
SBI Executive Enclave, Green Valley,
Banjara Hills, Hyderabad,
Telangana 500034
Phone: 040 4900 2222

© 2025 Dr. Reddy’s Laboratories Ltd. All rights reserved.

Dr. Reddy’s Laboratories, 8-2-337,
Banjara Hills Rd Number 3,
SBI Executive Enclave, Green Valley,
Banjara Hills, Hyderabad,
Telangana 500034
Phone: 040 4900 2222

  • Twitter

© 2025 Dr. Reddy’s Laboratories Ltd.
All rights reserved.

X

Let’s talk API sourcing live at

Tackle sourcing bottlenecks and compliance hurdles

Hall E1 Booth H28 24-26 June 2025, Shanghai

Book a Meeting